Software & Services
Etherstack plc (ASX:ESK), the Sydney based wireless technology company, has chalked up an early defence win with the Australian Department of Defence. The deal announced today is an opening $4.1m for technology and services as part of potential a multi-stage agreement.
Etherstack Plc (ASX:ESK) is pleased to report that its subsidiary Etherstack Pty Ltd has entered into a technology licensing contract with the Australian Department of Defence to supply Etherstack technology and associated delivery services to the Commonwealth of Australia.
Sportech has announced that is has since received a conditional proposal from a third party to acquire all of the shares in Sportech PLC, which among other things, remains subject to due diligence.
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that it has received firm commitments to raise A$50 million under a placement via the issue of approximately 83.3 million new fully paid ordinary shares at an offer price of A$0.60 to institutional and sophisticated investors.
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce it has entered into binding agreements to acquire global assets of leading international online sports betting company Sportech PLC for A$56.2million on a cash-free, debt-free basis.
BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to advise that the New Jersey Racing Commission has approved a pilot program to conduct Fixed Odds wagers to be accepted in New Jersey on Grade 1 stakes races.
The BetMakers' (ASX:BET) (FRA:T07) board and management are especially pleased by the Company's ability throughout FY20 to implement stages of its strategic plan and execute on the opportunities that are presenting in the global wagering landscape.
The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is pleased to announce it has received confirmation that a Bill which "authorizes fixed odds wagering on horse races through fixed odds wagering system" has been introduced to the New Jersey Legislature.
Etherstack (ASX:ESK) is pleased to present commentary on activities in Q3 FY20 and up to the date of this report, to accompany the lodgement of this Appendix 4C cash report for the quarter ending 30 September 2020.
BetMakers Technology Group Holdings Limited (ASX:BET) (FRA:T07) is pleased to advise investors and shareholders that Managing Director, Todd Buckingham, will be presenting as part of the Broker Briefing Wagering Webinar on Friday 30 October 2020.
Banking & Finance
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
Oil Gas & Energy
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Operations Update
- Desert Mountain Energy Corp. (CVE:DME): Natural Gas, AI Data Centers & Helium - The New Mexico Advantage
- TMK Energy Limited (ASX:TMK) LF-07 Pilot Production Gas Well Update
- Beetaloo Energy Australia Limited (ASX:BTL) SEAAOC Darwin 2025 Presentation
- Ellis Martin Report: Prairie Operating Co. (NASDAQ:PROP) CFO on Acquisitions, Growth and Shareholder Value
- Ellis Martin Report: Prairie Operating Co. (NASDAQ:PROP) Scales Production in Colorado's DJ Basin
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Board and Management Transition
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEso Precisely Detects Early Stage Esophageal Cancer
- BPH Energy Limited (ASX:BPH) Annual Financial Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Preliminary Final and Annual Report
- Advent Energy Limited June 2025 Financial Statements
- Ellis Martin Report: Redefining Cancer Treatment - RenovoRx, Inc. (NASDAQ:RNXT) CEO Shaun Bagai on Targeted Pancreatic Therapy